Share Price and Basic Stock Data
Last Updated: February 6, 2026, 9:23 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sagar Cements Ltd operates in the cement industry and has shown a notable increase in its revenue over the years. The company reported sales of ₹2,230 Cr for the fiscal year ending March 2023, a significant rise from ₹1,597 Cr in the previous fiscal year. However, the revenue for the fiscal year ending March 2025 is expected to decline slightly to ₹2,258 Cr, indicating potential challenges ahead. Quarterly sales figures have shown fluctuations, with the highest recorded sales of ₹709 Cr in March 2024, followed by a decrease to ₹561 Cr in June 2024. The trailing twelve months (TTM) sales stood at ₹2,494 Cr, reflecting overall growth compared to previous years. Despite these fluctuations, the company achieved a sales growth trajectory, demonstrating resilience in a competitive market. The cement sector has been facing headwinds due to rising input costs and fluctuating demand, impacting overall sector performance. Nonetheless, Sagar’s ability to maintain a robust revenue base suggests a competitive positioning within the industry.
Profitability and Efficiency Metrics
Sagar Cements’ profitability metrics indicate a challenging financial landscape. The company reported a net profit of -₹164 Cr for the TTM, reflecting ongoing operational struggles. The operating profit margin (OPM) was notably low at 6%, with variations seen in quarterly results, peaking at 18% in June 2025, but failing to maintain consistency. The interest coverage ratio stood at 0.86x, highlighting difficulties in covering interest expenses, which averaged around ₹46 Cr per quarter. Return on equity (ROE) has been reported at 10.3%, which is relatively low compared to industry standards. The company’s cash conversion cycle (CCC) remained negative at -225 days, indicating inefficiencies in managing working capital. These profitability challenges are compounded by high expenses, which reached ₹2,076 Cr in March 2023, reflecting rising costs in operations. Overall, while there are moments of operational profit, the persistent net losses and low margins suggest that Sagar Cements must address its efficiency and cost management strategies to improve profitability.
Balance Sheet Strength and Financial Ratios
The balance sheet of Sagar Cements presents a mixed picture of financial health. As of March 2025, total borrowings stood at ₹1,640 Cr against reserves of ₹1,656 Cr, indicating a precarious balance between debt and equity. The company has a debt-to-equity ratio of 0.82x, which is relatively high, suggesting increased financial leverage and potential risk during adverse market conditions. The current ratio was reported at 0.58, significantly below the ideal benchmark of 1, indicating liquidity concerns. The book value per share was ₹131.81, reflecting a decline from previous years, suggesting a weakening of shareholder equity. However, the price-to-book value ratio of 1.36x indicates that the market may still hold some confidence in the company’s long-term potential. Additionally, the interest coverage ratio of 0.86x points towards challenges in meeting interest obligations, which could pose risks in the event of cash flow disruptions. Therefore, while the company maintains a substantial asset base, its financial ratios highlight potential vulnerabilities that need addressing.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sagar Cements reflects a stable yet cautious investor sentiment. Promoters hold 48.33% of the company, which indicates a strong control over the operations. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), hold 2.84% and 17.39%, respectively, demonstrating a moderate level of institutional interest. The public holds 31.42% of shares, indicating a healthy retail investor base. However, over the past year, FII participation has decreased from 3.99% in December 2022 to 2.84% in December 2023, which may indicate a cautious approach by foreign investors amid the company’s financial struggles. The increase in the number of shareholders to 31,977 as of September 2025 suggests some level of retail confidence, although the decline in institutional holdings could raise concerns about the company’s appeal to larger investors. Overall, while promoter ownership remains strong, the fluctuations in institutional holdings highlight a need for Sagar Cements to enhance operational performance to regain investor confidence.
Outlook, Risks, and Final Insight
Looking ahead, Sagar Cements faces a challenging operational environment characterized by fluctuating demand and rising input costs. The company’s ability to navigate these challenges will be critical for restoring profitability and improving financial metrics. Key risks include continued operational losses and high leverage, which could strain cash flows, especially if market conditions worsen. Additionally, the company’s current ratio indicates potential liquidity issues, which could hinder its ability to capitalize on growth opportunities. On the other hand, strengths such as a solid market position and significant promoter backing could serve as a foundation for recovery. If Sagar Cements can implement effective cost management strategies and improve operational efficiency, it may stabilize its financial performance. Conversely, persistent losses and declining investor confidence may lead to further challenges. The path forward will require diligent management focus on enhancing profitability, addressing debt concerns, and ultimately restoring investor trust.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 18.3/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,74,851 Cr. | 12,722 | 13,102/10,048 | 48.2 | 2,444 | 0.61 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 27,442 Cr. | 1,161 | 1,209/788 | 142 | 322 | 0.17 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 14,024 Cr. | 453 | 490/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 8,705 Cr. | 215 | 309/197 | 23.4 | 74.4 | 0.46 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 37,341.93 Cr | 1,968.16 | 76.96 | 573.47 | 0.56% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 576 | 622 | 540 | 587 | 669 | 709 | 561 | 475 | 564 | 658 | 671 | 602 | 591 |
| Expenses | 528 | 583 | 509 | 527 | 582 | 641 | 514 | 455 | 526 | 621 | 549 | 551 | 553 |
| Operating Profit | 48 | 39 | 30 | 60 | 87 | 68 | 47 | 20 | 38 | 37 | 121 | 51 | 38 |
| OPM % | 8% | 6% | 6% | 10% | 13% | 10% | 8% | 4% | 7% | 6% | 18% | 9% | 6% |
| Other Income | 14 | 181 | 4 | 18 | 4 | 44 | 8 | 5 | 5 | -24 | 4 | 4 | 2 |
| Interest | 51 | 52 | 44 | 47 | 49 | 45 | 46 | 46 | 48 | 47 | 47 | 46 | 50 |
| Depreciation | 40 | 42 | 50 | 51 | 57 | 56 | 56 | 58 | 59 | 58 | 55 | 56 | 63 |
| Profit before tax | -29 | 126 | -59 | -20 | -15 | 10 | -48 | -79 | -64 | -93 | 24 | -47 | -74 |
| Tax % | -19% | 30% | -29% | -48% | -28% | -13% | -32% | -28% | -15% | -21% | 69% | -5% | -13% |
| Net Profit | -24 | 88 | -42 | -11 | -10 | 12 | -32 | -57 | -54 | -73 | 7 | -44 | -64 |
| EPS in Rs | -1.42 | 6.92 | -3.05 | -0.64 | -0.62 | 1.01 | -2.17 | -4.25 | -4.21 | -5.41 | 0.09 | -3.24 | -4.41 |
Last Updated: February 4, 2026, 8:46 am
Below is a detailed analysis of the quarterly data for Sagar Cements Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 591.00 Cr.. The value appears to be declining and may need further review. It has decreased from 602.00 Cr. (Sep 2025) to 591.00 Cr., marking a decrease of 11.00 Cr..
- For Expenses, as of Dec 2025, the value is 553.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 551.00 Cr. (Sep 2025) to 553.00 Cr., marking an increase of 2.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 38.00 Cr.. The value appears to be declining and may need further review. It has decreased from 51.00 Cr. (Sep 2025) to 38.00 Cr., marking a decrease of 13.00 Cr..
- For OPM %, as of Dec 2025, the value is 6.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Sep 2025) to 6.00%, marking a decrease of 3.00%.
- For Other Income, as of Dec 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Sep 2025) to 2.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Dec 2025, the value is 50.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 46.00 Cr. (Sep 2025) to 50.00 Cr., marking an increase of 4.00 Cr..
- For Depreciation, as of Dec 2025, the value is 63.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 56.00 Cr. (Sep 2025) to 63.00 Cr., marking an increase of 7.00 Cr..
- For Profit before tax, as of Dec 2025, the value is -74.00 Cr.. The value appears to be declining and may need further review. It has decreased from -47.00 Cr. (Sep 2025) to -74.00 Cr., marking a decrease of 27.00 Cr..
- For Tax %, as of Dec 2025, the value is -13.00%. The value appears to be improving (decreasing) as expected. It has decreased from -5.00% (Sep 2025) to -13.00%, marking a decrease of 8.00%.
- For Net Profit, as of Dec 2025, the value is -64.00 Cr.. The value appears to be declining and may need further review. It has decreased from -44.00 Cr. (Sep 2025) to -64.00 Cr., marking a decrease of 20.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is -4.41. The value appears to be declining and may need further review. It has decreased from -3.24 (Sep 2025) to -4.41, marking a decrease of 1.17.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:42 am
| Metric | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 270 | 425 | 753 | 814 | 1,038 | 1,218 | 1,175 | 1,371 | 1,597 | 2,230 | 2,505 | 2,258 | 2,494 |
| Expenses | 205 | 340 | 630 | 703 | 887 | 1,068 | 990 | 971 | 1,321 | 2,076 | 2,258 | 2,116 | 2,247 |
| Operating Profit | 65 | 85 | 123 | 110 | 151 | 150 | 186 | 400 | 276 | 153 | 247 | 141 | 247 |
| OPM % | 24% | 20% | 16% | 14% | 15% | 12% | 16% | 29% | 17% | 7% | 10% | 6% | 10% |
| Other Income | 1 | 6 | 4 | 4 | 7 | 2 | 4 | 8 | 13 | 223 | 68 | -6 | -10 |
| Interest | 16 | 30 | 42 | 62 | 59 | 63 | 61 | 47 | 92 | 202 | 185 | 188 | 189 |
| Depreciation | 21 | 29 | 35 | 48 | 54 | 66 | 79 | 81 | 93 | 156 | 214 | 231 | 227 |
| Profit before tax | 29 | 32 | 51 | 4 | 46 | 23 | 50 | 281 | 104 | 18 | -84 | -284 | -179 |
| Tax % | 32% | 37% | 13% | 193% | 42% | 41% | 47% | 34% | 43% | 48% | -38% | -24% | |
| Net Profit | 19 | 20 | 44 | -4 | 26 | 14 | 27 | 186 | 59 | 10 | -52 | -217 | -164 |
| EPS in Rs | 2.54 | 2.58 | 5.09 | -0.38 | 2.57 | 1.33 | 2.40 | 15.88 | 5.89 | 2.31 | -3.32 | -16.05 | -12.77 |
| Dividend Payout % | 29% | 24% | 20% | -78% | 31% | 38% | 21% | 8% | 12% | 30% | -21% | 0% |
YoY Net Profit Growth
| Year | 2009-2010 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 5.26% | -109.09% | 750.00% | -46.15% | 92.86% | 588.89% | -68.28% | -83.05% | -620.00% | -317.31% |
| Change in YoY Net Profit Growth (%) | 0.00% | -114.35% | 859.09% | -796.15% | 139.01% | 496.03% | -657.17% | -14.77% | -536.95% | 302.69% |
Sagar Cements Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2009-2010 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 12% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -254% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 26% |
| 3 Years: | 12% |
| 1 Year: | 26% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 0% |
| 3 Years: | -4% |
| Last Year: | -10% |
Last Updated: September 5, 2025, 1:15 pm
Balance Sheet
Last Updated: January 7, 2026, 4:20 pm
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 17 | 20 | 20 | 20 | 22 | 24 | 24 | 26 | 26 | 26 | 26 |
| Reserves | 184 | 198 | 532 | 743 | 759 | 823 | 944 | 1,167 | 1,232 | 1,968 | 1,915 | 1,697 | 1,656 |
| Borrowings | 252 | 231 | 434 | 487 | 478 | 509 | 491 | 809 | 1,510 | 1,478 | 1,444 | 1,448 | 1,640 |
| Other Liabilities | 95 | 122 | 264 | 259 | 281 | 375 | 460 | 547 | 583 | 621 | 863 | 950 | 1,074 |
| Total Liabilities | 545 | 565 | 1,247 | 1,509 | 1,539 | 1,728 | 1,918 | 2,546 | 3,349 | 4,093 | 4,248 | 4,121 | 4,396 |
| Fixed Assets | 382 | 378 | 957 | 1,001 | 1,053 | 1,244 | 1,384 | 1,301 | 2,048 | 3,168 | 3,250 | 3,109 | 3,041 |
| CWIP | 18 | 10 | 15 | 55 | 125 | 110 | 108 | 517 | 100 | 99 | 15 | 123 | 316 |
| Investments | 15 | 38 | 0 | 0 | 0 | 0 | 0 | 0 | 315 | 0 | 0 | 0 | 0 |
| Other Assets | 130 | 139 | 274 | 452 | 361 | 374 | 426 | 727 | 886 | 826 | 983 | 889 | 1,039 |
| Total Assets | 545 | 565 | 1,247 | 1,509 | 1,539 | 1,728 | 1,918 | 2,546 | 3,349 | 4,093 | 4,248 | 4,121 | 4,396 |
Below is a detailed analysis of the balance sheet data for Sagar Cements Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,656.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,697.00 Cr. (Mar 2025) to 1,656.00 Cr., marking a decrease of 41.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1,640.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,448.00 Cr. (Mar 2025) to 1,640.00 Cr., marking an increase of 192.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,074.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 950.00 Cr. (Mar 2025) to 1,074.00 Cr., marking an increase of 124.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 4,396.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,121.00 Cr. (Mar 2025) to 4,396.00 Cr., marking an increase of 275.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 3,041.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,109.00 Cr. (Mar 2025) to 3,041.00 Cr., marking a decrease of 68.00 Cr..
- For CWIP, as of Sep 2025, the value is 316.00 Cr.. The value appears strong and on an upward trend. It has increased from 123.00 Cr. (Mar 2025) to 316.00 Cr., marking an increase of 193.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,039.00 Cr.. The value appears strong and on an upward trend. It has increased from 889.00 Cr. (Mar 2025) to 1,039.00 Cr., marking an increase of 150.00 Cr..
- For Total Assets, as of Sep 2025, the value is 4,396.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,121.00 Cr. (Mar 2025) to 4,396.00 Cr., marking an increase of 275.00 Cr..
Notably, the Reserves (1,656.00 Cr.) exceed the Borrowings (1,640.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -187.00 | -146.00 | -311.00 | -377.00 | -327.00 | -359.00 | -305.00 | -409.00 | 275.00 | 152.00 | 246.00 | 140.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2009 | Mar 2010 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 34 | 36 | 39 | 36 | 33 | 35 | 42 | 27 | 28 | 22 | 30 | 33 |
| Inventory Days | 200 | 209 | 241 | 386 | 239 | 222 | 186 | 189 | 338 | 241 | 273 | 232 |
| Days Payable | 136 | 150 | 353 | 516 | 344 | 312 | 358 | 349 | 358 | 267 | 460 | 490 |
| Cash Conversion Cycle | 97 | 95 | -73 | -95 | -73 | -55 | -130 | -133 | 7 | -4 | -157 | -225 |
| Working Capital Days | 61 | 40 | -57 | -46 | -46 | -59 | -61 | -2 | -45 | -36 | -59 | -108 |
| ROCE % | 12% | 14% | 6% | 8% | 7% | 8% | 18% | 8% | 6% | 1% | -2% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Multi Asset Allocation Fund | 3,338,867 | 0.55 | 71.6 | 2,321,227 | 2025-12-28 21:50:56 | 43.84% |
| ICICI Prudential Commodities Fund | 2,068,421 | 1.3 | 44.35 | 1,460,012 | 2026-01-26 02:55:23 | 41.67% |
| ICICI Prudential Smallcap Fund | 1,598,527 | 0.41 | 34.28 | 2,691,812 | 2025-12-08 00:43:19 | -40.62% |
| HDFC Multi Cap Fund | 1,473,276 | 0.16 | 31.59 | N/A | N/A | N/A |
| ICICI Prudential Infrastructure Fund | 432,619 | 0.11 | 9.28 | N/A | N/A | N/A |
| SBI Comma Fund | 366,286 | 0.91 | 7.85 | N/A | N/A | N/A |
| ICICI Prudential Manufacturing Fund | 362,364 | 0.12 | 7.77 | N/A | N/A | N/A |
| ICICI Prudential Retirement Fund - Pure Equity | 121,228 | 0.16 | 2.6 | N/A | N/A | N/A |
| ICICI Prudential Regular Savings Fund | 98,558 | 0.06 | 2.11 | N/A | N/A | N/A |
| ICICI Prudential Retirement Fund - Hybrid Conservative | 3,281 | 0.08 | 0.07 | 60,925 | 2025-12-28 08:00:57 | -94.61% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 |
| Basic EPS (Rs.) | -16.58 | -3.98 | 0.66 | 5.03 | 80.24 |
| Diluted EPS (Rs.) | -16.58 | -3.98 | 0.66 | 5.03 | 80.24 |
| Cash EPS (Rs.) | 1.08 | 12.40 | 12.57 | 12.92 | 113.26 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 131.81 | 154.53 | 129.22 | 111.44 | 535.34 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 131.81 | 154.53 | 129.22 | 111.44 | 535.34 |
| Revenue From Operations / Share (Rs.) | 172.73 | 191.63 | 170.58 | 135.90 | 583.54 |
| PBDIT / Share (Rs.) | 12.43 | 22.96 | 28.76 | 24.61 | 173.71 |
| PBIT / Share (Rs.) | -5.22 | 6.57 | 16.84 | 16.72 | 139.43 |
| PBT / Share (Rs.) | -21.69 | -6.44 | 1.41 | 8.85 | 119.62 |
| Net Profit / Share (Rs.) | -16.58 | -3.98 | 0.65 | 5.03 | 78.98 |
| NP After MI And SOA / Share (Rs.) | -16.05 | -3.32 | 2.22 | 5.88 | 79.16 |
| PBDIT Margin (%) | 7.19 | 11.97 | 16.85 | 18.10 | 29.76 |
| PBIT Margin (%) | -3.02 | 3.43 | 9.87 | 12.30 | 23.89 |
| PBT Margin (%) | -12.55 | -3.35 | 0.82 | 6.51 | 20.49 |
| Net Profit Margin (%) | -9.59 | -2.07 | 0.38 | 3.70 | 13.53 |
| NP After MI And SOA Margin (%) | -9.29 | -1.73 | 1.30 | 4.33 | 13.56 |
| Return on Networth / Equity (%) | -12.17 | -2.23 | 1.77 | 5.50 | 15.44 |
| Return on Capital Employeed (%) | -2.29 | 2.56 | 7.20 | 7.50 | 15.91 |
| Return On Assets (%) | -5.02 | -0.99 | 0.75 | 2.05 | 7.22 |
| Long Term Debt / Equity (X) | 0.57 | 0.56 | 0.70 | 0.89 | 0.52 |
| Total Debt / Equity (X) | 0.82 | 0.74 | 0.89 | 1.20 | 0.61 |
| Asset Turnover Ratio (%) | 0.52 | 0.61 | 0.62 | 0.59 | 0.52 |
| Current Ratio (X) | 0.58 | 0.85 | 0.97 | 0.95 | 1.15 |
| Quick Ratio (X) | 0.35 | 0.55 | 0.62 | 0.67 | 0.90 |
| Inventory Turnover Ratio (X) | 7.77 | 1.59 | 1.59 | 1.72 | 1.46 |
| Dividend Payout Ratio (NP) (%) | -4.36 | -21.10 | 31.50 | 8.50 | 8.21 |
| Dividend Payout Ratio (CP) (%) | 43.65 | 5.35 | 4.95 | 3.63 | 5.73 |
| Earning Retention Ratio (%) | 104.36 | 121.10 | 68.50 | 91.50 | 91.79 |
| Cash Earning Retention Ratio (%) | 56.35 | 94.65 | 95.05 | 96.37 | 94.27 |
| Interest Coverage Ratio (X) | 0.86 | 1.62 | 1.86 | 3.13 | 8.77 |
| Interest Coverage Ratio (Post Tax) (X) | -0.01 | 0.63 | 1.04 | 1.64 | 4.99 |
| Enterprise Value (Cr.) | 3682.52 | 3981.14 | 3785.92 | 4295.75 | 2217.77 |
| EV / Net Operating Revenue (X) | 1.63 | 1.59 | 1.70 | 2.69 | 1.62 |
| EV / EBITDA (X) | 22.66 | 13.27 | 10.07 | 14.85 | 5.43 |
| MarketCap / Net Operating Revenue (X) | 1.04 | 1.09 | 1.11 | 1.82 | 1.22 |
| Retention Ratios (%) | 104.36 | 121.10 | 68.49 | 91.49 | 91.78 |
| Price / BV (X) | 1.36 | 1.40 | 1.51 | 2.31 | 1.39 |
| Price / Net Operating Revenue (X) | 1.04 | 1.09 | 1.11 | 1.82 | 1.22 |
| EarningsYield | -0.08 | -0.01 | 0.01 | 0.02 | 0.11 |
After reviewing the key financial ratios for Sagar Cements Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -16.58. This value is below the healthy minimum of 5. It has decreased from -3.98 (Mar 24) to -16.58, marking a decrease of 12.60.
- For Diluted EPS (Rs.), as of Mar 25, the value is -16.58. This value is below the healthy minimum of 5. It has decreased from -3.98 (Mar 24) to -16.58, marking a decrease of 12.60.
- For Cash EPS (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 3. It has decreased from 12.40 (Mar 24) to 1.08, marking a decrease of 11.32.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.81. It has decreased from 154.53 (Mar 24) to 131.81, marking a decrease of 22.72.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.81. It has decreased from 154.53 (Mar 24) to 131.81, marking a decrease of 22.72.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 172.73. It has decreased from 191.63 (Mar 24) to 172.73, marking a decrease of 18.90.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 12.43. This value is within the healthy range. It has decreased from 22.96 (Mar 24) to 12.43, marking a decrease of 10.53.
- For PBIT / Share (Rs.), as of Mar 25, the value is -5.22. This value is below the healthy minimum of 0. It has decreased from 6.57 (Mar 24) to -5.22, marking a decrease of 11.79.
- For PBT / Share (Rs.), as of Mar 25, the value is -21.69. This value is below the healthy minimum of 0. It has decreased from -6.44 (Mar 24) to -21.69, marking a decrease of 15.25.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -16.58. This value is below the healthy minimum of 2. It has decreased from -3.98 (Mar 24) to -16.58, marking a decrease of 12.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -16.05. This value is below the healthy minimum of 2. It has decreased from -3.32 (Mar 24) to -16.05, marking a decrease of 12.73.
- For PBDIT Margin (%), as of Mar 25, the value is 7.19. This value is below the healthy minimum of 10. It has decreased from 11.97 (Mar 24) to 7.19, marking a decrease of 4.78.
- For PBIT Margin (%), as of Mar 25, the value is -3.02. This value is below the healthy minimum of 10. It has decreased from 3.43 (Mar 24) to -3.02, marking a decrease of 6.45.
- For PBT Margin (%), as of Mar 25, the value is -12.55. This value is below the healthy minimum of 10. It has decreased from -3.35 (Mar 24) to -12.55, marking a decrease of 9.20.
- For Net Profit Margin (%), as of Mar 25, the value is -9.59. This value is below the healthy minimum of 5. It has decreased from -2.07 (Mar 24) to -9.59, marking a decrease of 7.52.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -9.29. This value is below the healthy minimum of 8. It has decreased from -1.73 (Mar 24) to -9.29, marking a decrease of 7.56.
- For Return on Networth / Equity (%), as of Mar 25, the value is -12.17. This value is below the healthy minimum of 15. It has decreased from -2.23 (Mar 24) to -12.17, marking a decrease of 9.94.
- For Return on Capital Employeed (%), as of Mar 25, the value is -2.29. This value is below the healthy minimum of 10. It has decreased from 2.56 (Mar 24) to -2.29, marking a decrease of 4.85.
- For Return On Assets (%), as of Mar 25, the value is -5.02. This value is below the healthy minimum of 5. It has decreased from -0.99 (Mar 24) to -5.02, marking a decrease of 4.03.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.57. This value is within the healthy range. It has increased from 0.56 (Mar 24) to 0.57, marking an increase of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.82. This value is within the healthy range. It has increased from 0.74 (Mar 24) to 0.82, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.52. It has decreased from 0.61 (Mar 24) to 0.52, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 0.58. This value is below the healthy minimum of 1.5. It has decreased from 0.85 (Mar 24) to 0.58, marking a decrease of 0.27.
- For Quick Ratio (X), as of Mar 25, the value is 0.35. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.35, marking a decrease of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.77. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 7.77, marking an increase of 6.18.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is -4.36. This value is below the healthy minimum of 20. It has increased from -21.10 (Mar 24) to -4.36, marking an increase of 16.74.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 43.65. This value is within the healthy range. It has increased from 5.35 (Mar 24) to 43.65, marking an increase of 38.30.
- For Earning Retention Ratio (%), as of Mar 25, the value is 104.36. This value exceeds the healthy maximum of 70. It has decreased from 121.10 (Mar 24) to 104.36, marking a decrease of 16.74.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 56.35. This value is within the healthy range. It has decreased from 94.65 (Mar 24) to 56.35, marking a decrease of 38.30.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 3. It has decreased from 1.62 (Mar 24) to 0.86, marking a decrease of 0.76.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.01. This value is below the healthy minimum of 3. It has decreased from 0.63 (Mar 24) to -0.01, marking a decrease of 0.64.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,682.52. It has decreased from 3,981.14 (Mar 24) to 3,682.52, marking a decrease of 298.62.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has increased from 1.59 (Mar 24) to 1.63, marking an increase of 0.04.
- For EV / EBITDA (X), as of Mar 25, the value is 22.66. This value exceeds the healthy maximum of 15. It has increased from 13.27 (Mar 24) to 22.66, marking an increase of 9.39.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.04, marking a decrease of 0.05.
- For Retention Ratios (%), as of Mar 25, the value is 104.36. This value exceeds the healthy maximum of 70. It has decreased from 121.10 (Mar 24) to 104.36, marking a decrease of 16.74.
- For Price / BV (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 1.40 (Mar 24) to 1.36, marking a decrease of 0.04.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.04. This value is within the healthy range. It has decreased from 1.09 (Mar 24) to 1.04, marking a decrease of 0.05.
- For EarningsYield, as of Mar 25, the value is -0.08. This value is below the healthy minimum of 5. It has decreased from -0.01 (Mar 24) to -0.08, marking a decrease of 0.07.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sagar Cements Ltd:
- Net Profit Margin: -9.59%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.29% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -12.17% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.01
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.35
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 76.96)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.82
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -9.59%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | Plot No. 111, Hyderabad Telangana 500033 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. K V Vishnu Raju | Chairman & Ind.Director |
| Dr. S Anand Reddy | Managing Director |
| Mr. S Sreekanth Reddy | Joint Managing Director |
| Mrs. S Rachana | Non Executive Director |
| Mrs. O Rekha | Independent Director |
| Mr. Ravichandran Rajagopal | Independent Director |
| Mr. Madhavan Ganesan | Nominee Director |
| Mrs. N Sudha Rani | Nominee Director |
| Mr. Jens Van Nieuwenborgh | Nominee Director |
FAQ
What is the intrinsic value of Sagar Cements Ltd?
Sagar Cements Ltd's intrinsic value (as of 07 February 2026) is ₹89.64 which is 53.79% lower the current market price of ₹194.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹2,537 Cr. market cap, FY2025-2026 high/low of ₹300/155, reserves of ₹1,656 Cr, and liabilities of ₹4,396 Cr.
What is the Market Cap of Sagar Cements Ltd?
The Market Cap of Sagar Cements Ltd is 2,537 Cr..
What is the current Stock Price of Sagar Cements Ltd as on 07 February 2026?
The current stock price of Sagar Cements Ltd as on 07 February 2026 is ₹194.
What is the High / Low of Sagar Cements Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sagar Cements Ltd stocks is ₹300/155.
What is the Stock P/E of Sagar Cements Ltd?
The Stock P/E of Sagar Cements Ltd is .
What is the Book Value of Sagar Cements Ltd?
The Book Value of Sagar Cements Ltd is 129.
What is the Dividend Yield of Sagar Cements Ltd?
The Dividend Yield of Sagar Cements Ltd is 0.00 %.
What is the ROCE of Sagar Cements Ltd?
The ROCE of Sagar Cements Ltd is 2.19 %.
What is the ROE of Sagar Cements Ltd?
The ROE of Sagar Cements Ltd is 10.3 %.
What is the Face Value of Sagar Cements Ltd?
The Face Value of Sagar Cements Ltd is 2.00.